Actively Recruiting
Phase II Study Comparing Four Combination Therapies for Patients With PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma
Led by Ming-Yuan Chen · Updated on 2025-09-18
208
Participants Needed
6
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to evaluate the safety and effectiveness of four different treatment combinations in adults with recurrent or metastatic nasopharyngeal carcinoma NPC who have not responded to at least one platinum-based chemotherapy and anti-PD-1PD-L1 therapy. This phase II trial uses a Bayesian adaptive design to adjust treatment assignments based on patient responses. The study focuses on patients whose cancer cannot be treated with local therapies and have shown resistance to prior immunotherapy. Participants are randomly assigned to one of four treatment groups Ivonescimab alone, Ivonescimab combined with Nimotuzumab, Liposomal Mitoxantrone combined with an anti-PD-1 antibody, or Liposomal Irinotecan combined with oral S-1. Treatments are given through intravenous infusions or oral medication following specified dosing schedules, with some treatments continuing until disease progression, intolerable side effects, or other study endpoints. The trial includes interim analyses to adjust treatment allocation based on response rates. Patients will have regular visits for monitoring treatment effects, safety, and disease status using imaging and other assessments. Researchers will measure outcomes such as overall response rate, progression-free survival, overall survival, duration of response, disease control rate, adverse events, and quality of life over one year. Participants will remain in the study until disease progression, unacceptable toxicity, withdrawal, or death. The total study duration varies by individual response and treatment course.
CONDITIONS
Brief Title
Combination Therapy for PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma: A Bayesian Adaptive Phase II Trial
Research Team
M
Mingyuan Chen
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here